Brief: Nanexa Signs Evaluation Deal With Pharmaceutical Company
30/08/2022 08:04
Aug 30 (Reuters) - Nanexa AB NANEXA.ST :
* NANEXA SIGNS EVALUATION AGREEMENT WITH A GLOBAL
PHARMACEUTICAL
COMPANY
* TODAY ANNOUNCE THAT COMPANY HAS SIGNED A MATERIAL TRANSFER
AND
FEASIBILITY STUDY AGREEMENT WITH AN OPTION TO LICENSE, WITH A
GLOBAL PHARMACEUTICAL COMPANY, FOR EVALUATION OF PHARMASHELL®
DRUG DELIVERY SYSTEM MAKING A DEPOT FORMULATION OF A SPECIFIC
COMPOUND
Source text for Eikon: ID:nMFN2kRywc
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))